An experimental drug, lecanemab, is being hailed as a breakthrough in Alzheimer's therapy after a clinical trial confirms that it slows the progression of cognitive decline in patients with early stages of the disease.

Experimental drug slows down cognitive decline in Alzheimer's patients: Here’s what you need to know

The US Foods and Drug Administration(FDA) on Monday approved Biogen's aducanumab drug for Alzheimer's patience. Breaking news: The FDA has approved Aducanumab, the first FDA-approved drug that delays decline due to Alzheimer’s.

In major breakthrough, US FDA approves new Alzheimer's drug

A federal panel will decide Friday whether to recommend approval of a controversial but potentially promising Alzheimers drug, which would be the first to come to market in nearly two decades.

Controversial Alzheimer’s drug faces critical test before FDA panel

biogen

Biogen, News on Biogen, stories on Biogen, articles on Biogen, Biogen stories at Wion, Biogen news, Biogen latest news